Russell Investments Group’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7K Buy
+788
New +$21.5K ﹤0.01% 3797
2022
Q1
Sell
-10,312
Closed -$288K 2746
2021
Q4
$288K Buy
10,312
+3,009
+41% +$98.7K ﹤0.01% 2623
2021
Q3
$304K Buy
7,303
+3,075
+73% +$129K ﹤0.01% 2646
2021
Q2
$195K Sell
4,228
-6,802
-62% -$337K ﹤0.01% 2914
2021
Q1
$607K Buy
11,030
+10,896
+8,131% +$722K ﹤0.01% 2448
2020
Q4
$9K Buy
+134
New +$15.7K ﹤0.01% 3007
2020
Q1
Sell
-1,562
Closed -$382K 3028
2019
Q4
$382K Sell
1,562
-3,312
-68% -$610K ﹤0.01% 2500
2019
Q3
$576K Buy
+4,874
New +$737K ﹤0.01% 2244

Other funds holding ASMB

Russell Investments Group's ASMB Position: Q2 2026 in Review

Russell Investments Group opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 788 shares worth $21.7K. The stake represents ﹤0.01% of the portfolio and ranks #3797 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in ASMB as recently as Q4 2021.

Russell Investments Group first reported a position in ASMB in Q3 2019 and has held it in 8 quarters since. The position peaked at $607K in Q1 2021. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Russell Investments Group held 788 shares of Assembly Biosciences worth $21.7K as of Q2 2026.
  • Assembly Biosciences was a new Russell Investments Group position in Q2 2026.
  • Assembly Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3797 holding.
  • Russell Investments Group first reported a position in Assembly Biosciences in Q3 2019 and has held it in 8 quarters since.
  • Russell Investments Group's Assembly Biosciences position peaked at $607K in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.